Get started
QIAGEN 24/31 CVQIAGEN 24/31 CVQIAGEN 24/31 CV

QIAGEN 24/31 CV

No trades
See on Supercharts
Overview
Analysis News

A3L06J chart


Full chart

Key terms


Outstanding amount
‪500.00 M‬ USD
Face value
200,000.00 USD
Minimum denomination
200,000.00 USD
Coupon
2.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
2.43%
Maturity date
Sep 10, 2031
Term to maturity
6 years

About QIAGEN 24/31 CV


Issuer
QIAGEN NV
Sector
Health Technology
Industry
Medical Specialties
Home page
qiagen.com
Issue date
Sep 10, 2024
ISIN
DE000A3L06J9
FIGI
BBG01PKJ6WS2
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

A3L06J analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

A3L06J news